LI hospital accepting patients for clinical trial testing vaccine against breast cancer
By Stacey Sager
Published on April 24, 2026.
A Long Island hospital is accepting patients for a worldwide phase 3 clinical trial for a new breast cancer vaccine, FLAMINGO-01. The vaccine is from Greenwich LifeSciences and aims to harness the patient's immune response to fight cancer. If successful, it could become the standard of care for breast cancer patients. The company has shown an 80 percent or greater reduction in metastatic breast cancer recurrence over five years of follow-up, compared to a 50 percent rate from other approved products.
Related Articles
New Mexico cannabis businesses see tax break potential after federal rescheduling
The US Department of Justice rescheduled cannabis products as a Schedule III drug, potentially benefiting New Mexico cannabis businesses and job creation.
Woman Claims She May Have Swallowed Human Fingertip In Her Trader Joe's Orange Juice: Reports
An Oregon woman is suing Trader Joe's for $10,000 after claiming she may have accidentally swallowed a human fingertip while drinking orange juice.
Marijuana advocacy groups meet with state officials following reclassification of state-licensed medical cannabis
Pro-cannabis groups in Indiana are discussing the Trump Administration’s reclassification of state-licensed medical marijuana, focusing on veterans' needs and safety concerns.